Register to receive a free Europe Market For Orthopedic Biomaterials – 2015 report synopsis and brochure
An article on our latest research regarding the European orthopedic biomaterials market was recently published on Med Device Online written by iData Research Analyst Scott McInnes, and CEO Kamran Zamanian. Scott was the lead researcher for the 2015 European Orthopedic Biomaterials Market report. He is currently working on the 2015 U.S. Market for Oncology Diagnostic and Intervention Devices.
The market for European orthopedic biomaterials (OB) has undergone dramatic changes over the last two years. Prices, quantities sold, and competitors have been in an almost constant state of flux. While quantities sold are marginally increasing, ASPs (average sales prices) are being driven down by an increase in competition.
Included in our analysis are the markets for bone morphogenetic proteins (BMPs), hyaluronic acid viscosupplementation injections, bone graft substitutes, and autologous chondrocyte implantations (ACIs).
While the entire OB market has been in a state of contraction over the past few years, especially following Olympus’s exit from the BMP market, it is expected to resume marginal growth in 2015. Of those four segments, the markets for autologous chondrocyte implantations and bone morphogenetic proteins have become monopolies.